A first‐in‐human study of CAL101, a monoclonal antibody targeting S100A4 - Jonas Hallén; Sylvia Vetrhus; Margrethe Sørgaard; Jörg Klingelhöfer; Signe Borchert; Ian Holyer; Shruthi Ramesh; Jörg H. W. Distler; Dave Singh (British Journal of Clinical Pharmacology, 2026)